This activity is intended for physicians, physician assistants, nurse practitioners, registered nurses, and other allied healthcare professionals specializing or certified in the areas of women’s health, gynecology, obstetrics, internal medicine, family or general medicine, geriatric medicine, emergency medicine, and preventive medicine.
Goals and Objectives
Cardiovascular Disease continues to be the leading cause of morbidity and mortality in the United States and now globally. Hypertension also remains one of the major risk factors for cardiovascular disease including heart disease (coronary heart disease, congestive heart failure, left ventricular hypertrophy, and arrhythmias) and cerebrovascular disease (stroke). Given this importance, reviewing the management and treatment of hypertension, heart disease, and stroke is critical to practicing clinicians and particularly those in primary care settings. Specifically, newer methods and treatment paradigms for increasing the control rates of hypertension are critically needed. Such new measures include more frequent patient office visits, the use of simple and standardized pharmacologic treatment algorithms, and fixed-dose combination pharmacologic anti-hypertensive therapy. The treatment of individuals with acute and chronic stroke especially when, how and to what level to lower an elevated blood pressure is critical to improving the morbidity and mortality of stroke. In addition, despite newer and effective therapies, the morbidity and mortality of congestive heart failure continues to be a major health issue. These areas will be reviewed and newer treatment modalities of these clinical conditions will be discussed. Upon completion of the activity, providers should be able to:
- Discuss, detail and emphasize newer treatment modalities to increase the control rates of individuals with hypertension through efforts to reduce clinical inertia such as the use of pharmacologic treatment algorithms and fixed-dose antihypertensive agents;
- Review the most recent guidelines on the acute and chronic treatment of stroke including when, how and to what level to reduce blood pressure when elevated;
- Implement newer treatment modalities in the treatment of chronic congestive heart failure and coronary artery disease.
CME Release Date: September 4, 2018
Valid for credit through: September 4, 2019
Course type: Video lecture
Southern Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credits™
Southern Medical Association designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board. All healthcare professionals who are not MDs or DOs will receive a certificate of participation.
Instructions for Participation and Credit
To successfully earn credit, participants must complete the activity online during the valid credit period noted, following these steps:
- Read the goals and objectives, accreditation information, and author disclosures.
- View the educational video of the lecture.
- Study the educational references.
- Online, choose the best answer to each test question. Learners must receive a passing score of 80%.
- Complete the activity evaluation and outcomes.
Upon successful completion of the test, evaluation and attestation, your certificate will be processed and emailed from email@example.com within approximately 1 hour. Credits will be archived for 6 years; at any point within this time period you may login to your account to print a duplicate copy of your certificate.
Click the Disclosure Tab above to review
Disclosure of Relevant Financial Relationships
As an organization accredited by the ACCME, Southern Medical Association requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest.
Southern Medical Association encourages Speakers/Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Donald J. DiPette, MD, FACP, FAHA
Dr. DiPette is currently the Health Sciences Distinguished Professor at the University of South Carolina and the University of South Carolina School of Medicine in Columbia, South Carolina. He has previously held the positions of Special Assistant to the Provost for Health Affairs, Vice President for Medical Affairs and Dean of the School of Medicine at the University of South Carolina. Before joining USC, he was Interim Senior Executive Dean and Interim Chief Academic Officer and Professor of Medicine in the Texas A&M Health Sciences Center College of Medicine and the Chairman of the Department of Medicine at Texas A&M Health Sciences Center College of Medicine and Scott & White Healthcare.
- Dr. DiPette has no relevant financial relationships to disclose.
- Dr. DiPette does not intend to discuss off-label or investigational uses of drugs, mechanical devices, biologics, or diagnostics not yet approved by the FDA for use in the United States.
The following planning committee members have no relevant financial relationships to declare:
Georgia L. Thomas, RN, MBA, HACP, FACHE, Nurse Planner
Nancy Phillips, MD, Physician Planner
Jennifer Price, MA, SMA CME Program Manager
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view your purchase options.
Create a free account, then purchase purchase access to this course.